Image

US-based firms MicroPort Orthopedics (MPO) and MB Innovations (MBI) have entered into a multi-product development agreement for orthopedic instruments.

Under the deal, MB Innovations will initially offer design and development expertise to support development of MicroPort’s portfolio of instruments and instrument systems associated with its Fast Recovery, tissue-sparing approach to hip arthroplasty procedures.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

During the agreement period, additional development programmes will be started to develop other differentiated implants and instruments that are used for both hip and knee arthroplasty procedures.

MPO chief executive officer Ted Davis said: "Troy and his team have an established track record of innovation and product commercialisation. I’m looking forward to the impact they can have on our product offering.

"Additional development programmes will be started to develop other differentiated implants and instruments that are used for both hip and knee arthroplasty procedures."

"We have already identified the initial programmes that leverage MPO’s ongoing efforts at innovative, tissue friendly arthroplasty techniques.

"I am confident that MBI will accelerate the pace at which we execute on our mission of delivering important and highly differentiated technologies to help surgeons care for their patients."

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

In January 2014, MicroPort Scientific had completed the acquisition of Wright Medical’s OrthoRecon business.

MPO is poised to capitalise on the macro trends of increasing globalisation and expanding the OrthoRecon business in the fast-growing emerging market economies, with the help of its China-based global parent.

The new products will allow MPO to enable surgeons to offer tissue-sparing surgical procedures to their patients that result in less pain and a quicker recovery from joint replacement surgery.

Image: MicroPort corporate headquarters in China. Photo: courtesy of MicroPort Scientific Corporation.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact